Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Cancer02:18

Cancer

55.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.4K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital-Based Careers in Pediatric Hematology-Oncology: The State of the Field and Future Needs.

Pediatric blood & cancer·2026
Same author

Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition network.

British journal of cancer·2025
Same author

Relapse patterns among children and adolescents with Kaposi sarcoma in Malawi.

Pediatric hematology and oncology·2025
Same author

Cough, Neck Pain, and Right Facial Paralysis in a 14-year-old with Autism.

Pediatrics in review·2023
Same author

Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease.

JCI insight·2023
Same author

Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis.

The Lancet. Oncology·2023

Related Experiment Video

Updated: Mar 19, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.7K

Pediatric Cancer Recognition Training in Botswana.

Jeremy S Slone1, Elise Ishigami2, Parth S Mehta1

  • 1Texas Children's Cancer and Hematology Centers, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA.

Global Pediatric Health
|June 24, 2016
PubMed
Summary

Training healthcare workers in Botswana improved recognition and referral of childhood cancers. This initiative in low- and middle-income countries (LMICs) addresses delayed presentation, a key barrier to improving pediatric cancer survival rates.

Keywords:
AfricaBotswanacancerdelayed presentationeducationpediatric cancerpediatric oncologytraining

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 19, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Healthcare Worker Training

Background:

  • Delayed presentation of childhood cancer significantly hinders survival rates in low- and middle-income countries (LMICs).
  • Botswana, with a population of 2 million, has a single pediatric cancer treatment center, Princess Marina Hospital (PMH).

Purpose of the Study:

  • To assess the impact of a pediatric cancer recognition training program on healthcare workers in Botswana.
  • To identify existing limitations in pediatric cancer knowledge and referral processes.

Main Methods:

  • A pediatric cancer recognition training program was implemented, reaching 50% of government hospitals in Botswana.
  • 362 healthcare workers were trained on recognizing and referring pediatric cancer cases to PMH.
  • Post-workshop evaluations were conducted to assess knowledge improvement.

Main Results:

  • The training program identified limitations in current pediatric cancer knowledge among healthcare workers.
  • Attendees showed significant improvement in understanding pediatric cancer signs and symptoms.
  • Knowledge of the referral process to PMH also improved post-training.

Conclusions:

  • Targeted training can enhance healthcare workers' ability to recognize and refer children with cancer in resource-limited settings.
  • Improving early detection and referral is crucial for improving pediatric cancer outcomes in LMICs.
  • The program demonstrated effectiveness in addressing knowledge gaps and improving the referral pathway.